reports
Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina Wor...
Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress MALVERN, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Arun Upadhyay, PhD, Chief Scientific Officer, Head of Research & Development, Ocugen will speak at the Retina World Congress (RWC) being held May 9-12, 2024 in Ft. Lauderdale, FL. “This is a terrific opportunity to share the most recent developments in modifier gene ...
NanoXplore to Host a Webcast to Discuss Third Quarter Results on May 1...
NanoXplore to Host a Webcast to Discuss Third Quarter Results on May 15th, 2024 MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore”) (TSX: GRA and OTCQX: NNXPF) is pleased to hold a webcast to discuss the results of its third quarter ended March 31, 2024, on Wednesday, May 15, 2024, at 8:30 a.m. Eastern Time. The financial results will be released on Tuesday, May 14, 2024, after the market close. Details of the Q3 Webcast When: May 15, 2024, at 8:30 a.m. Eastern Time Webcast: To listen to the live webcast, please join and register at: or via our website...
HII Reports First Quarter 2024 Results
HII Reports First Quarter 2024 Results Record first quarter revenues of $2.8 billion, up 4.9% compared to first quarter 2023Operating income of $154 million, up 9.2% compared to first quarter 2023Net earnings of $153 million or $3.87 diluted earnings per shareNew contract awards of $3.1 billion, resulting in backlog of $48.4 billionCompany reaffirms previously issued financial guidance1 NEWPORT NEWS, Va., May 02, 2024 (GLOBE NEWSWIRE) -- HII (NYSE: HII) reported first quarter 2024 revenues of $2.8 billion, up 4.9% from the first quarter of 2023, driven primarily by growth at its Mission ...
Draganfly to Showcase Latest UAV Technology at Special Operations Forc...
Draganfly to Showcase Latest UAV Technology at Special Operations Forces Week 2024 - Booth #3701 Tampa, Florida, May 02, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer is pleased to announce its participation in SOF Week 2024, the premier event for the international Special Operations Forces (SOF) community. Hosted in Tampa, Florida, from May 6 - 10, 2024, SOF Week 2024 is jointly sponsored by the United States Special Operations Command (USSOCOM) and t...
Alvotech Announces Participation at BofA Securities Healthcare Confere...
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024 Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of management would be participating in the upcoming BofA Securities Healthcare Conference 2024, which will be held on May 14-15, 2024 in Las Vegas, NV. Members of Alvotech’s management team will be attending the conference and hosting one-on-one meetings with investors. About AlvotechAlvotech is a biotech company, founded by Robert Wessma...
Alvotech tekur þátt í heilbrigðisráðstefnu BofA Securities í Bandaríkj...
Alvotech tekur þátt í heilbrigðisráðstefnu BofA Securities í Bandaríkjunum Alvotech (NASDAQ: ALVO) tilkynnti í dag að félagið taki þátt í árlegri heilbrigðisráðstefnu BofA Securities, sem haldin verður dagana 14. – 15. maí í Las Vegas, Nevadafylki Bandaríkjanna. Fulltrúar úr framkvæmdastjórn Alvotech munu taka þátt í ráðstefnunni og funda með fjárfestum. Um AlvotechAlvotech, stofnað af Róberti Wessman, er líftæknifyrirtæki sem einbeitir sér að þróun og framleiðslu líftæknihliðstæðulyfja fyrir sjúklinga um allan heim. Alvotech stefnir að því að verða leiðandi fyrirtæki á sviði líftæknihliðs...
Alvotech Announces Participation at BofA Securities Healthcare Confere...
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024 REYKJAVIK, Iceland, May 02, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of management would be participating in the upcoming BofA Securities Healthcare Conference 2024, which will be held on May 14-15, 2024 in Las Vegas, NV. Members of Alvotech’s management team will be attending the conference and hosting one-on-one meetings with investors. About Alvotech...
NanoXplore organise une webdiffusion pour discuter des résultats du tr...
NanoXplore organise une webdiffusion pour discuter des résultats du troisième trimestre le 15 mai 2024 MONTRÉAL, 02 mai 2024 (GLOBE NEWSWIRE) -- NanoXplore Inc. (" NanoXplore " ou la " Société ") (TSX : GRA et OTCQX : NNXPF) a le plaisir d'organiser une webdiffusion pour discuter des résultats de son troisième trimestre clos le 31 mars 2024, le mercredi 15 mai 2024, à 8h30, heure de l'Est. Les résultats financiers seront publiés le mardi 14 mai 2024, après la fermeture du marché. Détails de la webdiffusion du T3 Quand : 15 mai 2024, à 8h30, heure de l’Est Webdiffusion : Pour écou...
Vivid Seats Releases 2024 Environmental, Social and Governance Update
Vivid Seats Releases 2024 Environmental, Social and Governance Update CHICAGO, May 02, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: SEAT), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today published its 2024 Environmental, Social and Governance (ESG) Fact Sheet, providing new and updated performance metrics and progress against ongoing initiatives. “At Vivid Seats, sustainability and corporate responsibility play a vital role in our business strategy, and we are pleased ...
Wereldhave Nv: 2 directors
Two Directors at Wereldhave Nv bought 50,425 shares at 13.100EUR. The significance rating of the trade was 89/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Kuros Biosciences Ag: 1 director
A director at Kuros Biosciences Ag sold 7,181 shares at 6.955CHF and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Compagnie Financière Tradition S.A.: 1 director
A director at Compagnie Financière Tradition S.A. sold 184 shares at 144.000CHF and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
- Russell Waller
Swisscom (Neutral, TP: CHF610, +22%) Q1 24:Mixed numbers, weaker SR ...
Swisscom has reported a slightly mixed set of numbers. Swiss SR trends have deteriorated faster than expected; EBITDA is more in-line, but OpFCF and FCF are both light. We worry that Swiss SR trends will come under further pressure in the run-up to the Sunrise IPO, and as Salt starts to offer a fixed product to more of the country.
Pitney Bowes Declares Common Stock Dividend
STAMFORD, Conn.--(BUSINESS WIRE)-- Pitney Bowes Inc. (NYSE:PBI), a global shipping and mailing company that provides technology, logistics, and financial services, today announced that its Board of Directors has declared a quarterly cash dividend on the company’s common stock of $0.05 per share. The dividend will be paid on June 7, 2024 to stockholders of record on May 23, 2024. About Pitney Bowes Pitney Bowes (NYSE:PBI) is a global shipping and mailing company that provides technology, logistics, and financial services to more than 90 percent of the Fortune 500. Small business, retail, en...
EQS-News: MEDICLIN steigert Konzernumsatz und Betriebsergebnis im erst...
EQS-News: MEDICLIN AG / Schlagwort(e): Quartals-/Zwischenmitteilung MEDICLIN steigert Konzernumsatz und Betriebsergebnis im ersten Quartal 2024 02.05.2024 / 13:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Offenburg, 2. Mai 2024 MEDICLIN steigert Konzernumsatz und Betriebsergebnis im ersten Quartal 2024 MEDICLIN steigert seinen Konzernumsatz für das erste Quartal 2024 um 4,9 % auf 185,4 Mio. Euro Konzern-EBIT mit 4,1 Mio. Euro deutlich höher als im Vorjahreszeitraum (-1,7 Mio. Euro) Auslastung mit 85,1 % gegenüber Vorjahr ge...
EQS-News: MEDICLIN increases consolidated sales and operating result i...
EQS-News: MEDICLIN AG / Key word(s): Quarterly / Interim Statement MEDICLIN increases consolidated sales and operating result in the first quarter of 2024 02.05.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Offenburg, 2 May 2024 MEDICLIN increases consolidated sales and operating result in the first quarter of 2024 MEDICLIN increases its consolidated sales for the first quarter of 2024 by 4.9% to EUR 185.4 million Group EBIT of EUR 4.1 million significantly higher than in the same period of the previous year (EUR -1.7 m...
- Dan Salmon
Match Group (MTCH, Buy, $55 target) Quick Thoughts Ahead of Tuesday’s...
Ahead of Tuesday PM’s earnings report, we review key controversies for MTCH, including: 1. Tinder payers: the moment of truth approaches 2. The path to $1 billion in revenue for Hinge 3. Will MTCH outspend the 50% of FCF target for share buybacks again in 2024? We also review what to look for in the investor letter and listen for on the earnings call, our top questions for management, and potential positive and negative catalysts for MTCH.
Kimco Realty® Announces First Quarter 2024 Results
Kimco Realty® Announces First Quarter 2024 Results – Strong Growth and Leasing Activity – – Successful Execution on RPT Realty Acquisition – – Board Declares Quarterly Dividend – – Updates 2024 Outlook – JERICHO, N.Y., May 02, 2024 (GLOBE NEWSWIRE) -- Kimco Realty® (NYSE: KIM), a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States, today reported results for the first quarter ended March 31, 2024. For the three months ended March 31, 2024 and 2023, Kimco Realty’s n...
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent ...
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights - Completed additional enrollment in Phase 1B dose-expansion cohorts for TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) patients in the first quarter of 2024; updated combination data expected at the European Society of Hematology (EHA) 2024 Annual Meeting in June – - Randomized, controlled Phase 1B dose-expansion cohort in frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) patients expected to initiate enrollment in the second quarter of 2024 – - Presented preclinical data at the 2024 Americ...
Appian Announces First Quarter 2024 Financial Results
Appian Announces First Quarter 2024 Financial Results First quarter cloud subscription revenue increased 24% year-over-year to $86.6 million MCLEAN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced financial results for the first quarter ended March 31, 2024. “Appian continues to push technological boundaries in our industry, from AI-backed services to process mining. Organizations globally are recognizing the power and simplicity of the Appian Platform,” said Matt Calkins, CEO & Founder. First Quarter 2024 Financial Highlights: Revenue: Cloud subscription ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.